CALOSYN PHARMA, INC. — Form D
CALOSYN PHARMA, INC. of Shreveport, LA, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-29. The offering totals $2.1M, of which $310K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-02-29
- Form: D
- Accession: 0001429819-12-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.1M
- Amount sold: $310K
- Remaining: $1.8M
- Investors: 3
- Date of first sale: 2012-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-174155
Issuer
- Name: CALOSYN PHARMA, INC.
- CIK: 0001429819
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 2031 Kings Highway, Shreveport, LA, 71103
- Phone: 13182139240
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Ross Barrett | Director | Shreveport, LA |
| Joseph Lovett | Director | Houston, TX |
| Mike Sherman | Director | Durham, NC |
| Stephen Snowdy | Director | Brookhaven, GA |
| David Waddell | Director | Atlanta, 2Q |
| Stephen Snowdy | Executive Officer | Brookhaven, GA |
| Joseph P Lovett | Director | Baton Rouge, LA |
| Richard R Babb | Director | Baton Rouge, LA |
| Richard R Babb | Executive Officer | Baton Rouge, LA |
| David P Waddell | Director | Shreveport, LA |
| Ross P Barrett | Director | Shreveport, LA |
| Ross P Barrett | Executive Officer | Shreveport, LA |
| William R Grimes | Director | Kingwood, TX |
| William R Grimes | Executive Officer | Kingwood, TX |
| Joseph F Lovett | Director | Plymouth Meeting, PA |
| Ross F Barrett | Director | Baton Rouge, LA |
| David F Waddell | Director | Shreveport, LA |
| Stephen F Snowdy | Director | Memphis, TN |
| Stephen F Snowdy | Executive Officer | Memphis, TN |
| Martin Becker | Director | Sharon, MA |
| Martin Becker | Executive Officer | Sharon, MA |
Other filings by this issuer (3)
More